申请人:[en]ARCUS BIOSCIENCES, INC.
公开号:WO2022246177A1
公开(公告)日:2022-11-24
Compounds of Formula I that inhibit AXL, and compositions containing the compound(s) and methods for synthesizing the compounds, are described herein. Also described are the use of such compounds and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by AXL.